Join
Live feed
·
INSIDERFilingvia Quantisnow
Caris Life Sciences Inc. logo

SEC Form 4: Morris David B sold $50,427 worth of Series A Fixed to Floating Rate Redeemable Preferred Stock (1,947 units at $25.90) and sold $76,067 worth of Series B Fixed to Floating Rate Redeemable Preferred Stock (2,937 units at $25.90), closing all direct ownership in the company

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CAI (Caris Life Sciences Inc.) and more on Quantisnow.